Problem 17 - Cliffs Test Prep NCLEX-RN

Question

A month after receiving a blood transfusion an immunocompromised patient develops fever, liver abnormalities, a rash, and diarrhea. The nurse would suspect this patient has: 1\. nothing related to the blood transfusion. 2\. graft-versus-host disease (GVHD). 3\. myelosuppression. 4\. an allergic response to a recent medication.

Step-by-Step Solution

Answer

The nurse would suspect graft-versus-host disease (GVHD).

Step 1: Understand the Symptoms

Review the symptoms presented in the patient: fever, liver abnormalities, rash, and diarrhea. Note that these symptoms are seen a month after a blood transfusion in an immunocompromised patient.

Step 2: Analyze Associations with Blood Transfusion

Consider the conditions related to blood transfusions, especially in immunocompromised individuals. Graft-versus-host disease (GVHD) is a major complication where the donor's immune cells attack the patient's body, causing symptoms like fever, liver issues, skin rash, and gastrointestinal symptoms.

Step 3: Eliminate Unlikely Options

Evaluate each option based on the symptoms and patient context: - Option 1 (Nothing related to blood transfusion): Unlikely, given the timing and symptoms. - Option 3 (Myelosuppression): Generally causes reduced blood cell counts, not the present symptoms. - Option 4 (Allergic response to medication): Usually causes immediate reactions, less likely a month after transfusion.

Step 4: Confirm the Likely Diagnosis

Option 2 (GVHD) fits well with the symptoms and patient condition post-transfusion, as GVHD typically occurs in immunocompromised patients with symptoms matching those described.

Key Concepts

Graft-versus-host disease (GVHD)

Graft-versus-host disease (GVHD) is a serious complication often associated with certain medical procedures like bone marrow transplants or blood transfusions. In this condition, the immune cells from the donated tissue recognize the recipient's body as foreign and begin to attack it. This immune response can lead to various symptoms, including:

• Fever
• Liver abnormalities
• Rash
• Diarrhea

In immunocompromised patients, GVHD can manifest prominently because their weak immune system is unable to combat the attack effectively. The disease can have acute or chronic forms depending on the timing and duration of symptoms. Early diagnosis and intervention are key to managing GVHD effectively. Treatments often focus on suppressing the immune response and may include medications like corticosteroids to reduce inflammation.

Blood Transfusion Complications

Blood transfusions are generally safe but can sometimes lead to complications. These complications can be immune-mediated or non-immune reactions. In terms of immune responses, they can range from mild to severe.
Mild allergic reactions might present with symptoms like itching or rash soon after the transfusion. More severe responses include hemolytic reactions, where red blood cells are destroyed, or transfusion-related acute lung injury (TRALI), affecting the lungs.
For immunocompromised patients, the risks are heightened. They are particularly vulnerable to reactions such as GVHD, as their immune systems cannot adequately defend against the donor cells. Mitigating risks involves thorough screening and matching of donor blood and, where applicable, using specialized treatments like irradiated blood products to decrease the likelihood of complications.

Immunocompromised Patients

Immunocompromised patients have weakened immune systems that can arise from various conditions like cancer, HIV/AIDS, or treatments such as chemotherapy. This makes them more susceptible to infections and complications after procedures like blood transfusions.
Their compromised immunity means they cannot mount a proper defense against invaders, including any foreign cells introduced during blood transfusion. As a result, conditions like GVHD become of particular concern.
In managing such patients, healthcare providers must be vigilant and proactive in addressing potential complications. Strategies include close monitoring for any symptoms following transfusions and preventive measures like using blood products tailored to reduce risks, such as leukocyte-reduced or irradiated transfusions. Early intervention is crucial to manage any adverse reactions effectively.